Variable | Labels | n | % |
---|---|---|---|
Gender | Males | 132 | 61.4 |
 | Females | 83 | 38.6 |
Age | ≤ 60 | 87 | 40.5 |
 | 60+ | 128 | 59.5 |
PS | ≥ 90 | 25 | 11.1 |
 | = 80 | 75 | 33.2 |
 | = 70 | 74 | 19.5 |
 | = 60 | 40 | 17.7 |
 | ≤ 50 | 42 | 18.6 |
Location | Head | 147 | 68.4 |
 | Body | 52 | 24.2 |
 | Back ('tail") | 16 | 7.4 |
Therapy | Chemotherapy and surgery | 53 | 24.7 |
 | Chemotherapy only | 65 | 30.2 |
 | Surgery only | 24 | 11.2 |
 | None | 73 | 34.0 |
Surgery | Yes | 77 | 35.8 |
 | No | 138 | 64.2 |
Chemotherapy | Yes | 118 | 54.9 |
 | No | 97 | 45.1 |
Ploidy | < 2.2 | 20 | 8.8 |
 | 2.2–3.6 | 86 | 38.1 |
 | >3.6 | 120 | 53.1 |
Amylase | Yes | 23 | 10.7 |
 | No | 192 | 89.3 |
Grading | High | 14 | 6.5 |
 | Medium | 187 | 87.0 |
 | Low | 14 | 6.5 |
Primary tumor extent | 1 | 15 | 7.0 |
 | 2 | 60 | 27.9 |
 | 3 | 77 | 35.8 |
 | 4 | 63 | 29.3 |
CEA | ≤ 5 mg/dL | 72 | 33.5 |
 | >5 mg/dL | 143 | 66.5 |
CA 19-9 | ≤ 30 × normal | 30 | 14.0 |
 | >30 × normal | 185 | 86.0 |
Thrombophlebitis | Yes | 105 | 48.8 |
 | No | 110 | 51.2 |
Diabetes | Yes | 199 | 92.6 |
 | No | 16 | 7.4 |
CRP | Normal | 150 | 69.8 |
 | Increased | 35 | 16.3 |
 | Greatly increased | 30 | 14.0 |
Steatorrhoea | Yes | 99 | 46.0 |
 | No | 116 | 54.0 |
Albumin | Yes | 114 | 53.0 |
 | No | 101 | 47.0 |
Epoetin | Yes | 36 | 16.7 |
 | No | 179 | 83.3 |
Transfusion | Yes | 61 | 28.4 |
 | No | 154 | 71.6 |
Weight loss | None | 62 | 28.8 |
 | 1–5% | 31 | 14.4 |
 | 6–10% | 58 | 27.0 |
 | >10% | 64 | 29.8 |
Pain | None | 50 | 23.3 |
 | Pain 1 | 84 | 39.1 |
 | Pain 2 | 55 | 25.6 |
 | Pain 3 | 26 | 12.1 |
Metastases | None | 86 | 40.0 |
 | LN | 37 | 17.2 |
 | LIV | 7 | 3.3 |
 | AB | 29 | 13.5 |
 | LN-AB | 30 | 14.0 |
 | LIV-LN-AB | 26 | 12.1 |
Jaundice | Yes | 46 | 21.4 |
 | No | 169 | 78.6 |